These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25881026)

  • 1. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
    Jagarlamudi KK; Hansson LO; Eriksson S
    BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
    Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
    BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
    Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
    Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
    Jagarlamudi KK; L S; M Z; J O; P V; S E
    PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics.
    Kiran Kumar J; Sharif H; Westberg S; von Euler H; Eriksson S
    Vet J; 2013 Sep; 197(3):854-60. PubMed ID: 23831216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
    Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
    PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
    Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
    Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.
    Huang S; Lin J; Guo N; Zhang M; Yun X; Liu S; Zhou J; He E; Skog S
    Asian Pac J Cancer Prev; 2011; 12(2):497-505. PubMed ID: 21545220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays.
    Kumar JK; Holmgren S; Levedahl KH; Höglund M; Venge P; Eriksson S
    Biotechniques; 2020 Jun; 68(6):334-341. PubMed ID: 32336110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
    Jagarlamudi KK; Shaw M
    Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer.
    Li HX; Lei DS; Wang XQ; Skog S; He Q
    Oncol Rep; 2005 Jan; 13(1):145-9. PubMed ID: 15583816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.
    Luo P; He E; Eriksson S; Zhou J; Hu G; Zhang J; Skog S
    Eur J Cancer Prev; 2009 Jun; 18(3):220-4. PubMed ID: 19282758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
    Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
    Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients.
    Zhang J; Jia Q; Zou S; Zhang P; Zhang X; Skog S; Luo P; Zhang W; He Q
    Oncol Rep; 2006 Feb; 15(2):455-61. PubMed ID: 16391869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
    Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
    Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
    Sharif H; Hagman R; Wang L; Eriksson S
    Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer.
    Larsson AM; Bendahl PO; Aaltonen K; Jansson S; Forsare C; Bergqvist M; Jørgensen CLT; Rydén L
    Sci Rep; 2020 Mar; 10(1):4484. PubMed ID: 32161278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.
    Hanan S; Jagarlamudi KK; Liya W; Ellen H; Staffan E
    BMC Biochem; 2012 Jun; 13():12. PubMed ID: 22741536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
    Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
    Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
    He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
    Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.